EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudieOpen Access · CC BY 4.0

Comparison of different glycemic control indicators on incidence of acute kidney injury and long-term mortality in critically ill patients with atherosclerotic cardiovascular disease: A retrospective cohort study

Dan Zhang, Lin Shi, Jia Wang iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0343234 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift PLOS One, 2026. Verfasst von Dan Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, Atherosclerosis, Glycemic Control. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Advanced glycemic metrics may better reflect glucose dysregulation in critically ill patients than conventional indicators, but their comparative predictive value for adverse outcomes in atherosclerotic cardiovascular disease (ASCVD) patients remains unclear.

Methods

This retrospective study using the MIMIC-IV database assessed associations between stress hyperglycemia ratio (SHR), hemoglobin glycation index (HGI), and glycemic variability (GV) with acute kidney injury (AKI) and 365-day mortality in 2,820 ASCVD patients. Multivariable regression models, restricted cubic splines, and ROC curves evaluated predictive performance.

Results

During ICU stay, 38.4% developed AKI, and 17.9% died within one year. GV showed the strongest association with both AKI (Q4 vs. Q1, OR=4.98, 95%CI:3.00–8.26, P < 0.001) and mortality (Q3 vs. Q1, HR = 1.77, 95%CI:1.19–2.63, P = 0.005). SHR was associated with increased AKI risk (Q4 vs. Q2, OR=1.47, 95%CI:1.12–2.19, P = 0.04) and mortality (Q4 vs. Q2, HR = 1.26, 95%CI:1.06–1.69, P = 0.01), while HGI showed inverse association with mortality (Q4 vs. Q1, HR = 0.71, 95%CI:0.53–0.93, P = 0.01). GV yielded the highest predictive accuracy for AKI (AUC = 0.69) and mortality (AUC = 0.62). Subgroup analyses confirmed robustness across demographics.

Conclusions

Among critically ill ASCVD patients, GV outperformed SHR and HGI in predicting AKI and long-term mortality, underscoring its prognostic utility and supporting individualized glucose management in ICU settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryAtherosclerosisGlycemic ControlHumansCritical IllnessRetrospective StudiesFemaleMaleAgedMiddle AgedBlood GlucoseIncidenceIntensive Care UnitsHyperglycemiaGlycated HemoglobinRisk Factors

Substanzen

Blood GlucoseGlycated Hemoglobin

Autor:innen und Institutionen

  • Department of Nephrology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Department of Gastroenterology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, Jiangsu, China.

ORCID-Profile: Jia Wang

Zitieren

APA

Zhang, D., Shi, L., & Wang, J. (2026). Comparison of different glycemic control indicators on incidence of acute kidney injury and long-term mortality in critically ill patients with atherosclerotic cardiovascular disease: A retrospective cohort study. PLOS One. https://doi.org/10.1371/journal.pone.0343234

Vancouver

Zhang D, Shi L, Wang J. Comparison of different glycemic control indicators on incidence of acute kidney injury and long-term mortality in critically ill patients with atherosclerotic cardiovascular disease: A retrospective cohort study. PLOS One. 2026. doi:10.1371/journal.pone.0343234

BibTeX
@article{Zhang2026,
  author = {Zhang, Dan and Shi, Lin and Wang, Jia},
  title = {Comparison of different glycemic control indicators on incidence of acute kidney injury and long-term mortality in critically ill patients with atherosclerotic cardiovascular disease: A retrospective cohort study},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0343234}
}
Kostenlos starten →